ARCALIS
ARCALIS is a joint venture focused on developing mRNA pharmaceuticals and vaccines, and providing contract development and manufacturing organization (CDMO) services. The company aims to establish a comprehensive system for domestic mRNA vaccine production in Japan, addressing the need for timely vaccine availability. This includes developing manufacturing technologies and producing both active pharmaceutical ingredients and formulations.
Funding Round:
Funding Amount:
Date: 14-Nov-2024
Investors: Meiji Seika Pharma Co
Markets: Pharmaceuticals, Vaccines, mRNA Technology
HQ: Minami-soma City, Fukushima Prefecture, Japan
Founded: 2021
Website: https://corp.arcalis.co.jp/en/
LinkedIn: https://jp.linkedin.com/company/linkedin.com-company-corp-arcalis-co-jp
Crunchbase: https://www.crunchbase.com/organization/arcalis
Leave a Comment
Comments
No comments yet.